Rami Rahal

Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers

Gregory R. Hoffman, Rami Rahal, Frank P. Buxton et al. · Proceedings of the National Academy of Sciences · 2014 · 416 citations · Full text

Life Sciences, Genetics, Oncology +17

Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven Cancers

Vivek Subbiah, Justin F. Gainor, Rami Rahal et al. · Cancer Discovery · 2018 · 393 citations

Medicine, Oncology, Pharmacology +17

Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma

Rami Rahal, Mareike Frick, Rodrigo Romero et al. · Nature Medicine · 2013 · 332 citations

Medicine, Oncology, Pharmacology +16

Experiences of adult cancer survivors in transitions

Margaret I. Fitch, S. Zomer, Gina Lockwood et al. · Supportive Care in Cancer · 2018 · 99 citations · Full text

Nursing, Oncology, Cancer Control +14

APC/C-Cdh1-mediated degradation of the Polo kinase Cdc5 promotes the return of Cdc14 into the nucleolus

Clara Visintin, Brett N. Tomson, Rami Rahal et al. · Genes & Development · 2008 · 94 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17